Demand for nucleic acid testing has expanded rapidly in recent days as it has become normalized. In April this year, Li Jinming, deputy director of clinical testing at the National Health Commission, said to the public, "China has completed nucleic acid tests for about 11.5 billion people since the new crown outbreak."
Currently, many cities in China have proposed a 15-minute nucleic acid "sampling circle" to provide convenience for the public "should be taken as much as possible", "would like to take as much as possible". Under the policy, nucleic acid testing has become a necessity, and the market represented by nucleic acid testing services will expand. Enterprises are springing up, and on May 13, 2022, Guo Yanhong, an ombudsman of the Medical Affairs Bureau of the National Health Commission, said at a press conference of the State Council's Joint Prevention and Control Mechanism (JPCM) that there are already 13,100 healthcare institutions in the country that can carry out nucleic acid testing, and there are 153,000 professional technicians engaged in nucleic acid testing technology, and nucleic acid testing capacity has been able to reach single-tube 57 million tubes per day. According to Prism and related software, there are 104 listed companies involved in the new crown testing business in the broad sense, and roughly 20 core companies. Mass screening plus daily testing, different research organizations give the nucleic acid testing market size of about 100 billion, the new crown testing industry ushered in a spurt of development.
The main listed companies doing nucleic acid testing are: UW Genetics (300676), Wanfu Bio (300482), Mind Bio (002932), Anke Bio (300009), Thermo King Bio (688068) and so on.
Nucleic acid testing related concept stocks, Changhong Technology, the company's wholly owned subsidiary Shenzhen Park Mingsheng Medical Instrument Co., Ltd. is currently the main for the UW Gene, Myriad Medical and other customers to provide supporting reagent kits and consumable products. Daan gene, the company has obtained "new coronavirus (2019-nCoV) nucleic acid detection kit (fluorescence PCR method)" medical device registration certificate.
The substance of the nucleic acid test is the nucleic acid of the virus. Nucleic acid test is to look for the presence of nucleic acids of foreign invading viruses in the patient's respiratory specimens, blood or feces to determine whether they are infected by the new coronavirus. And to do a good job of normalizing prevention and control to accelerate the improvement of testing capacity, so carrying out nucleic acid and antibody testing is indispensable.